Point of view: Should COVID-19 patients be supplemented with vitamin D?Maturitas. 2020 Oct; 140:24-26.M
Abstract
Using Hill's methodology for exploring causality, we aimed to determine in early May 2020 whether evidence supports vitamin D as a biological determinant of COVID-19 outcomes. Vitamin D is a secosteroid hormone theoretically able to reduce COVID-19 risk through regulation of (i) the renin-angiotensin system, (ii) cellular innate and adaptive immunity, and (iii) physical barriers. Inverse associations were found between 25-hydroxyvitamin D concentrations and COVID-19 incidence and mortality. Randomized controlled trials testing vitamin D supplementation in the treatment of COVID-19 are in progress. Positive results in such studies would encourage the use of vitamin D supplements as an adjuvant treatment in COVID-19.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
32972631
Citation
Annweiler, Cédric, et al. "Point of View: Should COVID-19 Patients Be Supplemented With Vitamin D?" Maturitas, vol. 140, 2020, pp. 24-26.
Annweiler C, Cao Z, Sabatier JM. Point of view: Should COVID-19 patients be supplemented with vitamin D? Maturitas. 2020;140:24-26.
Annweiler, C., Cao, Z., & Sabatier, J. M. (2020). Point of view: Should COVID-19 patients be supplemented with vitamin D? Maturitas, 140, 24-26. https://doi.org/10.1016/j.maturitas.2020.06.003
Annweiler C, Cao Z, Sabatier JM. Point of View: Should COVID-19 Patients Be Supplemented With Vitamin D. Maturitas. 2020;140:24-26. PubMed PMID: 32972631.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Point of view: Should COVID-19 patients be supplemented with vitamin D?
AU - Annweiler,Cédric,
AU - Cao,Zhijian,
AU - Sabatier,Jean-Marc,
Y1 - 2020/06/08/
PY - 2020/05/14/received
PY - 2020/06/04/revised
PY - 2020/06/05/accepted
PY - 2020/9/25/entrez
PY - 2020/9/26/pubmed
PY - 2020/10/2/medline
KW - Biomarker
KW - COVID-19
KW - Causality
KW - SARS-CoV-2
KW - Treatment
KW - Vitamin D
SP - 24
EP - 26
JF - Maturitas
JO - Maturitas
VL - 140
N2 - Using Hill's methodology for exploring causality, we aimed to determine in early May 2020 whether evidence supports vitamin D as a biological determinant of COVID-19 outcomes. Vitamin D is a secosteroid hormone theoretically able to reduce COVID-19 risk through regulation of (i) the renin-angiotensin system, (ii) cellular innate and adaptive immunity, and (iii) physical barriers. Inverse associations were found between 25-hydroxyvitamin D concentrations and COVID-19 incidence and mortality. Randomized controlled trials testing vitamin D supplementation in the treatment of COVID-19 are in progress. Positive results in such studies would encourage the use of vitamin D supplements as an adjuvant treatment in COVID-19.
SN - 1873-4111
UR - https://www.unboundmedicine.com/medline/citation/32972631/Point_of_view:_Should_COVID_19_patients_be_supplemented_with_vitamin_D
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0378-5122(20)30292-9
DB - PRIME
DP - Unbound Medicine
ER -